Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.73 USD | +2.33% | -4.29% | +9.93% |
Sales 2024 * | 998M 1.36B | Sales 2025 * | 1.03B 1.41B | Capitalization | 516M 705M |
---|---|---|---|---|---|
Net income 2024 * | 15M 20.5M | Net income 2025 * | 28M 38.26M | EV / Sales 2024 * | 0.82 x |
Net Debt 2024 * | 304M 416M | Net Debt 2025 * | 300M 410M | EV / Sales 2025 * | 0.79 x |
P/E ratio 2024 * |
34.4
x | P/E ratio 2025 * |
17.9
x | Employees | 1,920 |
Yield 2024 * |
3.77% | Yield 2025 * |
3.72% | Free-Float | 49.9% |
Latest transcript on Phibro Animal Health Corporation
1 day | +2.33% | ||
1 week | -4.29% | ||
Current month | -1.55% | ||
1 month | -2.53% | ||
3 months | +9.18% | ||
6 months | +18.20% | ||
Current year | +9.93% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
Glenn David
DFI | Director of Finance/CFO | 52 | 02-08 |
Larry Miller
COO | Chief Operating Officer | 60 | 08-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
E. Corcoran
BRD | Director/Board Member | 77 | 08-04-30 |
Carol Wrenn
BRD | Director/Board Member | 63 | 10-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.33% | 27 M€ | -5.03% | - | |
0.32% | 29 M€ | -4.33% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 12.73 | +2.33% | 76,507 |
24-04-25 | 12.44 | -0.96% | 122,344 |
24-04-24 | 12.56 | -7.71% | 111,200 |
24-04-23 | 13.61 | +4.29% | 109,686 |
24-04-22 | 13.05 | -1.88% | 92,576 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.93% | 516M | |
-19.73% | 72.39B | |
-11.01% | 6.54B | |
+15.88% | 3.43B | |
-2.92% | 3.12B | |
-0.68% | 1.4B | |
-17.27% | 1.34B | |
-2.73% | 1.26B | |
-28.16% | 1.2B | |
-14.67% | 1.12B |
- Stock Market
- Equities
- PAHC Stock